Empowering Small Molecule Drug Discovery by Automatic DEL Screening
In this webinar, our expert speakers showcase our automatic DNA-encoded library (DEL) screening device, DELman.
DNA-encoded library technology has proven to be a powerful tool for drug discovery. There are now several DEL-derived candidates in clinical stage. DEL enables researchers to explore vast chemical space with millions to billions of compounds. With DELman and other self-service data analysis tools, we show how researchers can wield DEL screens in appointed scenarios to obtain stable and reliable screening outcomes.
Related Content
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
VIEW RESOURCEMolecular glues are molecules that can encourage two proteins to interact when they otherwise may not. As a consequence, they...
VIEW RESOURCE